Stage FocusSeed, Series A
GeographyUS
TypeLongevity-Focused Biotech VC
Last Activity—
Industry Focus
Industries
BiotechSynthetic Biology
Technical BenchLimited
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Longevity Fund, founded in 2014 by Laura Deming — who joined MIT's aging biology lab at age 14 — is a San Francisco-based pioneer that helped establish longevity therapeutics as a venture category. With $37M across three funds, the firm invests at seed and Series A in senolytics, aging biology, and healthspan-extending therapeutics. Portfolio companies including Unity Biotechnology, Precision Bios...
Similar Funds
Civilization Ventures
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyAI InfrastructureSeedSeries A
SciFounders
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyPre-SeedSeed
4BIO Capital
Geneva, Switzerland
DeepTech NativeBiotechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Accelerator Life Science Partners
Seattle, United States
DeepTech NativeBiotechMedTechSeedSeries A
Age1
San Francisco, United States
DeepTech NativeBiotechSeedSeries A